You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SARS-CoV-2 antibody response

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster

Terminated
  • Anti-SARS-CoV-2 Antibody Response
  • blood and saliva samples will be taken
  • Graz, Austria
    Medizinische Universität Graz, Klinische Abteilung für Rheumatol
Jan 9, 2023

Effect of SARS-CoV-2 Vaccination in Liver Transplant Recipients

Completed
  • SARS-CoV-2 Vaccination
  • Liver Transplantation
  • Immunoassay, by ECLIA, for the quantitative in vitro determination of antibodies (including IgG) to the SARS - CoV - 2 spike protein (S) anti-RBD (receptor-binding domain) in serum and plasma samples.
  • Roma, Italy
    Policlinico Tor Vergata
Aug 3, 2022

Children Aged 5-11 Years Following Vaccination Against COVID-19

Recruiting
  • COVID-19 Vaccine
    • Petach Tikva, Israel
      Schneider Children's Medical Center
    Jan 24, 2022

    Covid19 Trial in Örebro (L. reuteri DSM 17938 + vitamin D, Placebo + vitamin D)

    Completed
    • Covid19
    • L. reuteri DSM 17938 + vitamin D
    • Placebo + vitamin D
    • Örebro, Örebro Län, Sweden
      Örebro University
    Oct 14, 2021

    Vaccine Reaction Trial in Venice-Lido (blood sample collection)

    Active, not recruiting
    • Vaccine Reaction
    • blood sample collection
    • Venice-Lido, Italy
      IRCCS San Camillo
    Aug 24, 2022

    Long COVID, Post-Acute Sequela of COVID-19, Post-Acute COVID-19 Trial in San Francisco (AER002, Placebo)

    Not yet recruiting
    • Long COVID
    • +2 more
    • San Francisco, California
      UCSF/Zuckerberg San Francisco General Hospital
    Jun 2, 2023

    Profiling Spike Protein Antibody Response Post COVID Booster

    Not yet recruiting
    • SARS-CoV-2 Booster
    • Spike Protein IgG Antibody
    • Obtain antibody titers
    • (no location specified)
    Jul 25, 2022

    Sarcoidosis, SARS-CoV2 Infection, Vaccine Response Impaired Trial in Chicago (Assay of (1) the level of anti-spike IgG antibody,

    Recruiting
    • Sarcoidosis
    • +2 more
    • Assay of (1) the level of anti-spike IgG antibody, and (2) interferon-gamma release in response to SARS-CoV-2 antigen stimulation
    • Chicago, Illinois
      Northwestern Medicine
    Dec 6, 2021

    Determine Antibody Levels After Receiving COVID-19 Boosters of

    Completed
    • SARS-CoV-2
      • San Mateo, California
        Evidation Health
      Oct 12, 2022

      Following COVID-19 Vaccination in Patients With Down Syndrome.

      Recruiting
      • Down Syndrome
      • SARS-CoV-2 Vaccination
      • Immune response to Sars-CoV-2 vaccinations; including COVID-19 vaccin Moderna, Comirnaty (Pfizer) and Vaxzevria (AstraZeneca)
      • Utrecht, Netherlands
        UMC utrecht
      Dec 9, 2021

      Healthy Adult Volunteers Trial in Taipei City (ChAdOx1-nCov-19 (Astra-Zeneca), SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine)

      Completed
      • Healthy Adult Volunteers
      • ChAdOx1-nCov-19 (Astra-Zeneca)
      • SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine
      • Taipei City, X, Taiwan
        National Taiwan University Hospital
      Oct 16, 2022

      Covid-19 Vaccine Response in Elderly Subjects

      Active, not recruiting
      • Covid19 Vaccine
      • Specific antibody and cellular immune response after anti-SARS-CoV-2 vaccine administration
      • Lille, France
        CHU lille
      Apr 28, 2022

      Disease Modifying Therapies on COVID-19 Outcomes and Antibody

      Recruiting
      • Multiple Sclerosis
      • COVID-19 (Severe Coronavirus Disease 2019)
      • data collection
      • analysis of blood samples
      • Aarau, Switzerland
      • +6 more
      Apr 11, 2022

      COVID-19, Vaccine Immune Response, Vaccine Adverse Reaction Trial in Incheon, Seoul, Suwon (mRNA-1273 COVID-19 vaccine)

      Recruiting
      • COVID-19
      • +2 more
      • mRNA-1273 COVID-19 vaccine
      • Incheon, Korea, Republic of
      • +4 more
      Feb 25, 2022

      Vaccine Reaction Trial in Lahore (booster vaccine for COVID 19)

      Active, not recruiting
      • Vaccine Reaction
      • booster vaccine for COVID 19
      • Lahore, Punjab, Pakistan
        Lahore General Hospital
      Feb 12, 2022

      Hemodialysis and Non-dialysis Patients Diagnosed With COVID-19.

      Completed
      • Dialysis
      • Covid19
        • Saint Petersburg, Russian Federation
          Saint-Petersburg State University Hospital
        Aug 2, 2021

        Kidney Transplant Recipients, Liver Transplant Recipients Trial in United States (Pfizer-BioNTech COVID-19 Vaccine Booster,

        Recruiting
        • Kidney Transplant Recipients
        • Liver Transplant Recipients
        • Pfizer-BioNTech Bivalent COVID-19 Vaccine
        • +3 more
        • San Diego, California
        • +14 more
        Oct 31, 2022

        HIV Seropositivity, Immunodeficiency, Vaccination Reaction Trial in Ghent (Blood draw)

        Recruiting
        • HIV Seropositivity
        • +3 more
        • Blood draw
        • Ghent, East Flanders, Belgium
          UH Ghent
        Jan 4, 2023

        SARS-CoV2 Infection Trial in Flint (General SARS-CoV-2 Communication, Rural-Targeted SARS-CoV-2 Communication)

        Recruiting
        • SARS-CoV2 Infection
        • General SARS-CoV-2 Communication
        • Rural-Targeted SARS-CoV-2 Communication
        • Flint, Michigan
          Flint Journal Building
        Oct 10, 2023

        Sars-Covid-19 Vaccines in Haematological Patients: Prospective

        Completed
        • Hematologic Diseases
        • IgG antibodies to Sars-Cov-2
        • QuantiFERON SARS-CoV-2 test
        • Monza, Lombardia, Italy
          San Gerardo Hospital
        Jan 23, 2023

        Influenza, COVID-19, Influenza Immunogencity Trial in United States (Simultaneous Vaccination (Influenza Vaccine and mRNA COVID

        Not yet recruiting
        • Influenza
        • +3 more
        • Simultaneous Vaccination (Influenza Vaccine and mRNA COVID booster)
        • +2 more
        • Phoenix, Arizona
        • +7 more
        Aug 30, 2023

        SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease

        Not yet recruiting
        • Metabolic Associated Fatty Liver Disease
        • Recombinant protein vaccine and adenovirus vector vaccine
        • (no location specified)
        Feb 12, 2023

        Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

        Not yet recruiting
        • Immunogenicity
        • Safety
        • Phase II:SWIM816;SARS-Cov-2;
        • +3 more
        • (no location specified)
        Jun 18, 2023

        Certain Disorders Involving the Immune Mechanism Trial in Tours (Sampling, PCR (polymerase chain reaction) SARS-CoV-2)

        Not yet recruiting
        • Certain Disorders Involving the Immune Mechanism
        • Sampling
        • PCR (polymerase chain reaction) SARS-CoV-2
        • Tours, France
          CHRU de Tours
        Nov 17, 2023

        SARS-CoV-2 RBD Antibody in My Duc Hospital Healthcare Workers

        Completed
        • Covid19
        • Vaccine Reaction
        • SARS-CoV-2 IgG II Quant
        • Ho Chi Minh City, Tan Binh, Vietnam
          HOPE Research Center, My Duc Hospital
        Aug 20, 2022